Sterne, Kessler, Goldstein and Fox P.L.L.C.
Polynucleotides encoding VEGF/DLL4 binding agents
The present invention relates to VEGF-binding agents, DLL4-binding agents, VEGF/DLL4 bispecific binding agents, and methods of using the agents for treating diseases such as cancer. The present invention provides antibodies that specifically bind human VEGF, antibodies that specifically bind human DLL4, and bispecific antibodies that specifically bind human VEGF and/or human DLL4. The present invention further provides methods of using the agents to inhibit tumor growth. Also described are methods of treating cancer comprising administering a therapeutically effect amount of an agent or antibody of the present invention to a patient having a tumor or cancer.
ONCOMED PHARMACEUTICALS, INC.
C C A A A C A C C A C A A C C A C C A C A C
C07K C07K A61P A61P A61K C07K A61K C07K C07K A61K C07K A61K A61K C07K C07K A61K C07K C07K A61K C07K A61K C07K
inventional additional inventional inventional additional inventional inventional additional additional inventional additional inventional inventional additional inventional inventional additional inventional inventional inventional inventional inventional
Christopher John Aaron Ken Austin L.
Bond Sato Gurney